Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bifidobacterium quadruplex viable tablets (Silankang) for constipation during pregnancy
ChiCTR2300068849Phase 3Not yet recruiting
- Sponsor
- West China Second University Hospital
- Start
- Mar 2021
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in constipation comparing Silankang with Placebo (2 arms). Primary endpoint: Responder rate for complete spontaneous bowel movements at week 8. Planned start Mar 2021; status: not yet recruiting.
02
Drugs
Bifidobacterium quadruplex viable tablets
03
Conditions
constipation
Beyond the preview
Go deeper on ChiCTR2300068849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300068849.